ロード中...
Tiagabine add‐on therapy for drug‐resistant focal epilepsy
BACKGROUND: Epilepsy is a common neurological condition that affects up to 1% of the population. Nearly 30% of people with epilepsy are resistant to currently available antiepileptic drugs (AEDs) and require treatment with multiple antiepileptic drugs in combination. Tiagabine is one of the newer AE...
保存先:
| 出版年: | Cochrane Database Syst Rev |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2019
|
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6953346/ https://ncbi.nlm.nih.gov/pubmed/31608990 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001908.pub4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|